GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Cyclically Adjusted Revenue per Share

Kobayashi Pharmaceutical Co (TSE:4967) Cyclically Adjusted Revenue per Share : 円2,215.69 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Kobayashi Pharmaceutical Co's adjusted revenue per share for the three months ended in Dec. 2024 was 円687.601. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円2,215.69 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Kobayashi Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Kobayashi Pharmaceutical Co was 6.20% per year. The lowest was 1.90% per year. And the median was 3.20% per year.

As of today (2025-05-27), Kobayashi Pharmaceutical Co's current stock price is 円5136.00. Kobayashi Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was 円2,215.69. Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 2.32.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Kobayashi Pharmaceutical Co was 7.06. The lowest was 2.29. And the median was 4.46.


Kobayashi Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,806.34 1,850.37 1,977.12 2,091.43 2,215.69

Kobayashi Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,105.16 2,137.40 2,164.48 2,215.69 -

Competitive Comparison of Kobayashi Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Kobayashi Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kobayashi Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=687.601/110.7000*110.7000
=687.601

Current CPI (Dec. 2024) = 110.7000.

Kobayashi Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 383.000 97.900 433.076
201506 368.040 98.400 414.045
201509 411.025 98.500 461.934
201512 501.056 98.100 565.412
201603 404.093 97.900 456.926
201606 457.352 98.100 516.094
201609 468.267 98.000 528.951
201612 570.578 98.400 641.900
201703 389.904 98.100 439.983
201706 464.388 98.500 521.906
201709 510.631 98.800 572.134
201712 621.337 99.400 691.972
201803 426.535 99.200 475.982
201806 492.766 99.200 549.891
201809 544.933 99.900 603.845
201812 653.932 99.700 726.081
201903 401.239 99.700 445.508
201906 480.293 99.800 532.750
201909 535.675 100.100 592.400
201912 603.073 100.500 664.280
202003 408.262 100.300 450.594
202006 438.430 99.900 485.828
202009 497.281 99.900 551.041
202012 581.669 99.300 648.447
202103 387.255 99.900 429.120
202106 470.594 99.500 523.565
202109 519.504 100.100 574.516
202112 610.093 100.100 674.698
202203 421.712 101.100 461.756
202206 499.715 101.800 543.403
202209 556.612 103.100 597.643
202212 679.295 104.100 722.363
202303 439.962 104.400 466.511
202306 527.506 105.200 555.085
202309 597.546 106.200 622.866
202312 724.022 106.800 750.461
202403 490.799 107.200 506.823
202406 493.025 108.200 504.417
202409 555.872 108.900 565.060
202412 687.601 110.700 687.601

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Kobayashi Pharmaceutical Co  (TSE:4967) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kobayashi Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5136.00/2215.69
=2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Kobayashi Pharmaceutical Co was 7.06. The lowest was 2.29. And the median was 4.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Kobayashi Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co Headlines

No Headlines